OrbiMed’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $27.7M | Buy |
|
|||||
|
2021
Q1 | $15.6M | Sell |
|
|||||
|
2020
Q4 | $26.4M | Sell |
|
|||||
|
2020
Q3 | $250M | Buy |
|
|||||
|
2020
Q2 | $242M | Buy |
|
|||||
|
2020
Q1 | $186M | Buy |
|
|||||
|
2019
Q4 | $180M | Sell |
|
|||||
|
2019
Q3 | $163M | Sell |
|
|||||
|
2019
Q2 | $252M | Sell |
|
|||||
|
2019
Q1 | $265M | Sell |
|
|||||
|
2018
Q4 | $199M | Sell |
|
|||||
|
2018
Q3 | $401M | Sell |
|
|||||
|
2018
Q2 | $388M | Sell |
|
|||||
|
2018
Q1 | $364M | Buy |
|
|||||
|
2017
Q4 | $344M | Sell |
|
|||||
|
2017
Q3 | $511M | Sell |
|
|||||
|
2017
Q2 | $471M | Buy |
|
|||||
|
2017
Q1 | $450M | Buy |
|
|||||
|
2016
Q4 | $415M | Buy |
|
|||||
|
2016
Q3 | $323M | Sell |
|
|||||
|
2016
Q2 | $348M | Buy |
|
|||||
|
2016
Q1 | $260M | Sell |
|
|||||
|
2015
Q4 | $434M | Buy |
|
|||||
|
2015
Q3 | $348M | Buy |
|
|||||
|
2015
Q2 | $370M | Buy |
|
|||||
|
2015
Q1 | $98M | Buy |
|
|||||
|
2014
Q4 | $61.4M | Buy |
|
|||||
|
2014
Q3 | $51.7M | Hold |
|
|||||
|
2014
Q2 | $48.8M | Buy |
|
|||||
|
2014
Q1 | $40.6M | Buy |
|
|||||
|
2013
Q4 | $30.9M | Buy |
|
|||||
|
2013
Q3 | $25.1M | Buy |
|
|||||
|
2013
Q2 | $17.8M | Buy |
|